- Home
- ACFN vs ASRT Comparison
ACFN vs ASRT Comparison
Compare ACFN & ASRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACFN
- ASRT
- Stock Information
- Founded
- ACFN 1986
- ASRT 1995
- Country
- ACFN United States
- ASRT United States
- Employees
- ACFN N/A
- ASRT N/A
- Industry
- ACFN Military/Government/Technical
- ASRT Biotechnology: Pharmaceutical Preparations
- Sector
- ACFN Consumer Discretionary
- ASRT Health Care
- Exchange
- ACFN Nasdaq
- ASRT Nasdaq
- Market Cap
- ACFN 76.5M
- ASRT 79.1M
- IPO Year
- ACFN N/A
- ASRT 1997
- Fundamental
- Price
- ACFN $29.28
- ASRT $0.91
- Analyst Decision
- ACFN
- ASRT Strong Buy
- Analyst Count
- ACFN 0
- ASRT 1
- Target Price
- ACFN N/A
- ASRT $3.00
- AVG Volume (30 Days)
- ACFN 21.8K
- ASRT 316.5K
- Earning Date
- ACFN 11-06-2025
- ASRT 11-10-2025
- Dividend Yield
- ACFN N/A
- ASRT N/A
- EPS Growth
- ACFN 1520.82
- ASRT N/A
- EPS
- ACFN 2.84
- ASRT N/A
- Revenue
- ACFN $13,202,000.00
- ASRT $117,099,000.00
- Revenue This Year
- ACFN N/A
- ASRT N/A
- Revenue Next Year
- ACFN N/A
- ASRT $6.75
- P/E Ratio
- ACFN $9.98
- ASRT N/A
- Revenue Growth
- ACFN 50.98
- ASRT N/A
- 52 Week Low
- ACFN $17.22
- ASRT $0.51
- 52 Week High
- ACFN $33.00
- ASRT $1.16
- Technical
- Relative Strength Index (RSI)
- ACFN N/A
- ASRT 58.21
- Support Level
- ACFN N/A
- ASRT $0.87
- Resistance Level
- ACFN N/A
- ASRT $0.93
- Average True Range (ATR)
- ACFN 0.00
- ASRT 0.05
- MACD
- ACFN 0.00
- ASRT -0.00
- Stochastic Oscillator
- ACFN 0.00
- ASRT 54.32
About ACFN Acorn Energy Inc. Common Stock
Acorn Energy Inc is a holding company that focuses on technology-driven solutions for energy infrastructure asset management. It operates through two segments namely, the PG segment and the CP segment. PG segment provides wireless remote monitoring and control systems and services for critical assets as well as Internet of Things applications which account for the majority of the revenue. CP segment is engaged in providing remote monitoring of cathodic protection systems on gas pipelines for gas utilities and pipeline companies.
About ASRT Assertio Holdings Inc.
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older and Zipsor, liquid-filled capsules for relief of mild to moderate pain.